FDA Approves Bayer’s Nubeqa for Wider Use in Prostate Cancer Subtype.
In combination with docetaxel, the U.S. Food and Drug Administration (FDA) has approved Bayer’s Nubeqa for the treatment of hormone-sensitive metastatic prostate cancer (mHSPC).Nubeqa (darolutamide) was previously approved for the treatment of non-metastatic castration-resistant prostate ... [Read]
The Phase 1b study by Aligos Therapeutics to assess its Class II Capsid Assembly modulator, ALG-000184, started with a 12-week dosing cohort.
The clinical-stage biopharmaceutical company Aligos Therapeutics, Inc. (Nasdaq:ALGS), which focuses on creating novel treatments for unmet medical needs in viral and liver diseases, announced today that enrollment in a 12-week dosing cohort of HBeAg-positive chronic ... [Read]
Emergent executes a letter of intent to acquire Evolutionary Biologics; former L’Oréal president Jim Morrison will become Emergent’s full-time chief executive officer.
Emergent Health Corp. (“Emergent”) (OTC PINK:EMGE) announces it has executed a Letter of Intent to acquire Evolutionary Biologics, Inc. Biologics, Inc. is a new type of biologics company with a specific mission: to provide the ... [Read]
Why Psychedelics Could Soon Replace Antidepressants
Anxiety disorders are the most common mental illness in the US, affecting approximately 40 million adults each year, and despite the abundance of antianxiety medications available, treatment resistance occurs in roughly 30% of patients. Anxiety ... [Read]
Chronic Disease Increasing Need for Specialty Pharmacy Services
The average American’s lifespan may have increased to 78 years old, but chronic diseases are are still prevalent. According to the CDC, six in 10 adults in the US have a chronic disease and it ... [Read]
Psilocybin and MDMA Get the Green Light for Medical Use in Canada
After facing legal scrutiny for decades, psychedelics including MDMA and psilocybin received a stamp of approval from Health Canada for medical purposes. Canada’s legislation now permits the use of psychedelics beyond palliative care, something health ... [Read]
Senate Bill Decriminalizing Psychedelics Could Help Reverse Some ‘War on Drugs’ Impacts
The global need for effective mental health treatment has led to the growing push for the legalization of psychedelic therapies, pushing the market into the mainstream. Last week, Michigan Senator Jeff Irwin introduced legislation that ... [Read]
$10 Billion Sackler Opioid Settlement Closes Chapter, Psychedelic Chapter Begins
The damage done by the opioid epidemic has caused families grief and loss, but recent developments in the case against Purdue Pharma will see some restitution for the family. A potential $10 billion will be ... [Read]
New COVID-19 Vaccine Mandates Make Rapid COVID Tests More Essential Than Ever
With the number of new COVID cases surging, fueled by a highly contagious Delta variant and only 50% of the US population having been vaccinated, rapid COVID tests and treatments are more important than ever. ... [Read]
Psychedelics Gain More Traction as New Research Aims to Address Chronic Pain and Mental Illness
The early 1970s saw psychedelics and psilocybin products made illegal in the US in the war on drugs. Decades later, new research indicates the medical potential of psilocybin and psychedelics in the treatment of chronic ... [Read]